SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is drawing attention after a recent rebound that traders say held its gains, with bullish technical setups and positioning ahead of earnings. The upbeat view contrasts with concerns that high rates and a sluggish housing market could continue to weigh on renovation demand.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers sharp rally to fresh multi-year highs is drawing attention, with traders citing rotation into defensive, dividend-paying pharma stocks and positioning ahead of the quarterly report. Bulls see a technical breakout and pipeline momentum, while skeptics warn the move may meet resistance and point to patent-expiration and growth concerns.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 77,397.34014094 USD and is up 0.28 over the last 24 hours. It is currently trading on 12773 active market(s) with $12,152,377,915.37 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoin is drawing attention amid concerns over Binances reported major hack and paused withdrawals, with traders debating whether damaged exchange trust could trigger further selling. Others argue the market is absorbing the shock and point to Binances reported reimbursement progress and planned withdrawal reopening as reasons for optimism.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Attention centers on expected Q3 results and the Phase 3 QUILT-2.005 topline for ANKTIVA plus BCG in BCG-naive bladder cancer; the trial is database-locked, with a supplemental filing planned if results support it. Bullish traders see the readout and ANKTIVAs expanded bladder-cancer label as growth catalysts, while others question commercial uptake and point to competition, short-selling, and broader market weakness to explain the volatility.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is drawing attention as traders use the leveraged inverse Nasdaq ETF to hedge or bet on further weakness in tech, citing concerns about AI spending and valuations alongside recent tech-led selling. The community is divided: some expect more downside, while others warn that rumors of a U.S.Iran deal and a possible market rebound could reverse gains in the short ETF.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The Dow is being discussed amid volatile, uneven trading across major indexes, with traders watching Fed policy and rising Treasury yields as pressures on equities. Some see relative strength in the Dow as money rotates away from tech, while others warn that inflation, oil-market risks and weakening momentum could deepen a selloff.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Discussion centers on BioCrysts upcoming quarterly results and whether continued ORLADEYO growth can support the stock despite its weak performance. Traders are also looking ahead to Navenibart and Netherton data, while debating managements acquisition strategy and expressing frustration over dilution and limited shareholder returns; buyout talk remains speculative.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys quarterly results and outlook are drawing attention, with traders highlighting stronger streaming profitability and resilient theme-park performance. The reaction is mixed: some see support for a turnaround, while others point to the stocks persistent range-bound price action and difficulty holding gains.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is drawing attention ahead of its upcoming earnings report, with traders watching whether guidance holds and how management addresses pressure on the pharmacy benefit management business. Some see the recent pullback as a potential technical rebound setup, while others remain cautious after the stocks recent selling.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

A sharp volatility spike has lifted UVIX, drawing traders seeking a hedge against a broader market pullback. The community is split between expecting volatility to persistciting concerns about oil, interest rates and geopolitical risksand warning that UVIX can quickly lose value as volatility fades and its leveraged futures exposure decays.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Unloading: Thomas Robert Dechant Sells $999K Worth Of IBEX Shares

Disclosed on September 16, Thomas Robert Dechant, Chief Executive Officer at IBEX (NASDAQ:IBEX), executed a substantial insider sell as per the latest SEC filing.
What Happened: After conducting a thorough analysis,read more...

Chief People Officer Of IBEX Makes $100K Sale

Joseph Paul Inson, Chief People Officer at IBEX (NASDAQ:IBEX), executed a substantial insider sell on September 16, according to an SEC filing.
What Happened: According to a Form 4 filing with the U.S. Securities andread more...

Director Of IBEX Sold $221K In Stock

Mingzhe Zhuang, Director at IBEX (NASDAQ:IBEX), reported an insider sell on September 16, according to a new SEC filing.
What Happened: Zhuang's decision to sell 5,522 shares of IBEX was revealed in a Form 4 filingread more...

Full Transcript: IBEX Q4 2026 Earnings Call

IBEX (NASDAQ:IBEX) released fourth-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below.
This transcript is brought to you by Benzinga APIs. For real-time access to ourread more...

IBEX (IBEX) Expected to Announce Quarterly Earnings on Wednesday

IBEX (NASDAQ:IBEX) will be releasing its Q3 2026 earnings after the market closes on Wednesday, May 6. (View Earnings Report at...

IBEX (NASDAQ:IBEX) Director Daniella Ballou-Aares Sells 6,000 Shares

IBEX Limited (NASDAQ:IBEX - Get Free Report) Director Daniella Ballou-Aares sold 6,000 shares of the company's stock in a transaction dated Thursday, March 13th. The shares were sold at an average...

Insider Selling: IBEX (NASDAQ:IBEX) Director Sells 6,000 Shares of Stock

IBEX Limited (NASDAQ:IBEX - Get Free Report) Director Daniella Ballou-Aares sold 6,000 shares of the business's stock in a transaction dated Thursday, March 13th. The stock was sold at an average...

IBEX (NASDAQ:IBEX) Director Daniella Ballou-Aares Sells 500 Shares

IBEX Limited (NASDAQ:IBEX - Get Free Report) Director Daniella Ballou-Aares sold 500 shares of the company's stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of...

JPMorgan Chase & Co. Raises Stake in IBEX Limited $IBEX

JPMorgan Chase & Co. boosted its holdings in IBEX Limited (NASDAQ:IBEX - Free Report) by 37.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 347,583...

IBEX Limited (NASDAQ:IBEX) Short Interest Up 18.3% in February

IBEX Limited (NASDAQ:IBEX - Get Free Report) was the target of a large growth in short interest during the month of February. As of February 27th, there was short interest totaling 190,084 shares, a...

IBEX Ltd. is a business process outsourcing company, which engages in technology-enabled customer lifecycle experience solutions. It also specializes in digital marketing, lead generation, online sales, optimization, lead conversion, customer service, billing support, technical support, multi-lingual, omni-channel, retention, renewals, up and cross sell, and win-backs. The company was founded in 1984 and is headquartered in Washington, DC.

IBEX Ltd

IBEX Stock Soars On Record Revenue, Upbeat Guidance: Retail’s Yet To Be Convinced

Equity

Neutral Sentiment

Shares of IBEX soared over 11% on Friday after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/02/06/3022435/0/en/IBEX-Reports-Record-Quarterly-Revenue-and-Strong-EPS.html">reported</a> record quarterly revenue and topped Wall Street estimates on earnings.Revenue rose 6.1% year-over-year (YoY) to a record high of $140.68 million during the quarter, beating a Wall Street estimate of $133.96 million. Adjusted earnings per share (EPS) came in at $0.59 versus an analyst estimate of $0.51.Net income rose 52.6% YoY to $9.27 million, primarily led by the impact of revenue growth, particularly in higher margin offshore regions, improved gross margin performance, and fewer diluted shares outstanding compared to the prior-year quarter.The firm raised its fiscal 2025 guidance and expects revenue to be in the range of $525 to $535 million versus a previous range of $515 to $525 million. Adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) are expected to be in the range of $68 to $69 million versus a previous range of $67 to $69 million.CEO Bob Dechant said the second quarter saw the highest revenue growth for the firm in two years with revenues growing over 6%. “Our growth continues to be driven by winning new clients and increasing market share within our embedded base clients. These key wins resulted in 14% revenue growth in our most profitable offshore regions,” he said.Despite the positive news, retail sentiment on Stocktwits dipped into the ‘neutral’ territory (42/100), accompanied by high retail chatter.<figure class="image"><img style="aspect-ratio:1872/428;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_02_07_at_12_52_16_PM_d6f335bb25.png" alt="IBEX’s Sentiment Meter and Message Volume as of 12:38 p.m. ET on Feb. 7, 2025 | Source: Stocktwits" width="1872" height="428"><figcaption>IBEX’s Sentiment Meter and Message Volume as of 12:38 p.m. ET on Feb. 7, 2025 | Source: Stocktwits</figcaption></figure>According to The Fly, RBC Capital analyst Daniel Perlin raised the firm's price target on the stock to $24 from $21 while keeping a ‘Sector Perform’ rating on the shares. Baird analyst David Konig raised the firm's price target on the shares to $28 from $26 while keeping an ‘Outperform’ rating.<a href="https://stocktwits.com/symbol/IBEX">IBEX shares</a> have gained over 13% in 2025 and have risen over 42% over the past year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/elliott-investment-calls-emersons-265-dollar-price-for-azpn-highly-opportunistic/chPzpAlRsC">Elliott Investment Calls Emerson’s $265 Apiece Offer For Aspen Tech Shares ‘Highly Opportunistic:’ Retail’s On Wait-And-Watch Mode</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market data with uptrend vector | Illustration Source: Getty Images

Revenue rose 6.1% year-over-year (YoY) to a record high of $140.68 million during the quarter, beating a Wall Street estimate of $133.96 million. Adjusted earnings per share (EPS) came in at $0.59 versus an analyst estimate of $0.51.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$44.73
Prev Close	$45.35
Open	$45.54
Dividend Yield	0.00%
50-Day Moving Average	$42.17
Beta	0.70
Avg. Volume	170,846.06
PE Ratio	14.29

52-Week High	$48.17
52-Week Low	$25.94
Market Capitalization	$596.89M
EPS (Annual)	$3.13
Price to Book	3.50
Revenue Per Employee	$18,402.17

Feed

News

Sentiment

Earnings

Fundamentals

Info

IBEX Fundamentals